Carol Aghajanian Selected Research

Carol Aghajanian Research Topics

Disease

86	Neoplasms (Cancer) 10/2022 - 08/2002
78	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 02/2002
35	Carcinoma (Carcinomatosis) 04/2022 - 02/2002
21	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 10/2004
21	Ovarian Epithelial Carcinoma 01/2021 - 02/2002
19	Disease Progression 01/2021 - 04/2004
7	Neutropenia 01/2022 - 08/2007
7	Leiomyosarcoma 01/2017 - 06/2002
6	Hypertension (High Blood Pressure) 07/2022 - 01/2010
6	Fatigue 01/2022 - 12/2007
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2007
6	Anemia 01/2022 - 01/2017
6	Nausea 10/2021 - 02/2016
5	Fallopian Tube Neoplasms 12/2021 - 06/2012
5	Hypersensitivity (Allergy) 05/2019 - 03/2002
4	Carcinosarcoma 01/2017 - 09/2012
3	Asthenia 10/2021 - 02/2016
3	Diarrhea 01/2019 - 09/2006
3	Abdominal Pain (Pain, Abdominal) 01/2019 - 05/2004
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 01/2019
2	Residual Neoplasm 01/2022 - 02/2008
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 07/2005
2	Thrombocytopenia (Thrombopenia) 10/2021 - 12/2019
2	Leukopenia 01/2021 - 01/2010
2	Granulosa Cell Tumor 01/2020 - 03/2015
2	Microsatellite Instability 01/2019 - 12/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 10/2002
2	Hemorrhage 01/2017 - 07/2015
2	Hyponatremia 01/2017 - 08/2007
2	Brain Neoplasms (Brain Tumor) 02/2013 - 10/2002
2	Testicular Neoplasms (Testicular Cancer) 12/2012 - 05/2008
2	Lymphoma (Lymphomas) 12/2012 - 03/2007
1	Chromosomal Instability (Chromosome Stability) 01/2022

Drug/Important Bio-Agent (IBA)

39	PlatinumIBA 01/2022 - 03/2002
22	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2002
22	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 03/2002
21	Bevacizumab (Avastin)FDA Link 10/2022 - 08/2006
12	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 06/2015
10	rucaparibIBA 12/2021 - 10/2017
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2004
8	olaparibIBA 01/2022 - 02/2016
8	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2015
7	veliparibIBA 01/2022 - 06/2015
7	Gemcitabine FDA Link 04/2014 - 06/2002
6	Pharmaceutical PreparationsIBA 01/2021 - 12/2004
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021 - 02/2016
5	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
5	EnzymesIBA 01/2017 - 08/2004
4	temsirolimus FDA Link 10/2022 - 04/2013
4	AntigensIBA 07/2022 - 05/2008
4	pembrolizumabIBA 08/2021 - 01/2019
4	ixabepilone (BMS 247550)FDA Link 01/2018 - 03/2007
4	ImmunosorbentsIBA 06/2011 - 08/2004
3	VaccinesIBA 07/2022 - 12/2012
3	MK 2206IBA 04/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2018
3	Peptides (Polypeptides)IBA 01/2021 - 05/2008
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2019
3	taxaneIBA 02/2016 - 08/2007
3	Bortezomib (Velcade)FDA Link 11/2009 - 08/2002
2	Combined VaccinesIBA 07/2022 - 12/2019
2	Biological ProductsIBA 01/2022 - 01/2022
2	peposertibIBA 01/2022 - 12/2019
2	Poly Adenosine Diphosphate RiboseIBA 12/2021 - 01/2021
2	atezolizumabIBA 10/2021 - 10/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 12/2019
2	TubulinIBA 10/2020 - 01/2017
2	fosbretabulin (combretastatin A4)IBA 10/2020 - 01/2016
2	lenvatinibIBA 10/2020 - 01/2019
2	IpilimumabIBA 01/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 12/2019 - 12/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 06/2002
2	GSK2141795IBA 12/2019 - 12/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 06/2011
2	human ALK1-Fc fusion proteinIBA 01/2018 - 07/2015
2	iniparibIBA 02/2016 - 09/2012
2	Glutamic Acid (Glutamate)FDA Link 02/2013 - 11/2004
2	Epothilones (Epothilone)IBA 12/2012 - 03/2007
2	Estrogens (Estrogen)FDA Link 03/2012 - 09/2004
2	Monoclonal AntibodiesIBA 06/2011 - 09/2006
2	Proteasome InhibitorsIBA 12/2004 - 08/2002
1	Hormones (Hormone)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 10/2022 - 02/2002
50	Therapeutics 04/2022 - 02/2002
4	Retreatment 05/2019 - 03/2002
4	Radiotherapy 11/2018 - 10/2002
3	Cytoreduction Surgical Procedures 10/2021 - 05/2006
3	Immunotherapy 01/2020 - 10/2019
3	Adjuvant Chemotherapy 03/2015 - 12/2004
3	Lymph Node Excision (Lymph Node Dissection) 10/2013 - 11/2006
2	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 10/2021
2	Salpingo-oophorectomy 01/2022 - 01/2021
2	Hysterectomy 01/2022 - 11/2006
2	Neoadjuvant Therapy 01/2020 - 03/2016
2	Aftercare (After-Treatment) 01/2018 - 12/2003
2	Premedication 03/2010 - 11/2004